Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - SHORT-TERM DEBT
Short-term Debt GERN - Geron Corporation
47.8 M
LAST VALUE
415.26%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR